Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAPA
3626
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $5.29M | ﹤0.01% |
537,489
-275,000
| -34% | -$2.78M |
|
3627
Modine Manufacturing
MOD
$11.5B
| $5.29M | ﹤0.01% |
88,669
+68,874
| +348% | +$3.37M |
|
3628
CALL
Caleres
CAL
$446M
| $5.29M | ﹤0.01% |
172,100
-900
| -0.5% | -$25.4K |
|
|
SHYF
3629
DELISTED
The Shyft Group
SHYF
| $5.27M | ﹤0.01% |
431,623
-35,591
| -8% | -$435K |
|
|
AXNX
3630
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.27M | ﹤0.01% |
84,718
-665,408
| -89% | -$37.2M |
|
3631
Arcus Biosciences
RCUS
$3.76B
| $5.27M | ﹤0.01% |
275,924
-9,923
| -3% | -$159K |
|
3632
NatWest
NWG
$75.7B
| $5.27M | ﹤0.01% |
935,614
+896,358
| +2,283% | +$4.76M |
|
3633
PUT
Intellia Therapeutics
NTLA
$1.69B
| $5.27M | ﹤0.01% |
172,700
+66,100
| +62% | +$1.9M |
|
3634
PUT
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
| $5.26M | ﹤0.01% |
61,700
+20,600
| +50% | +$1.54M |
|
3635
CALL
Kulicke & Soffa
KLIC
$5.33B
| $5.26M | ﹤0.01% |
96,100
+3,900
| +4% | +$189K |
|
3636
Syndax Pharmaceuticals
SNDX
$1.76B
| $5.25M | ﹤0.01% |
242,985
-192,508
| -44% | -$2.96M |
|
|
VZIO
3637
DELISTED
VIZIO Holding Corp.
VZIO
| $5.25M | ﹤0.01% |
681,525
-192,268
| -22% | -$1.2M |
|
3638
PUT
Fastly Inc
FSLY
$4.63B
| $5.24M | ﹤0.01% |
294,400
+5,400
| +2% | +$91.1K |
|
3639
PUT
Northern Oil and Gas
NOG
$2.72B
| $5.24M | ﹤0.01% |
141,300
+1,900
| +1% | +$71.8K |
|
3640
Rhythm Pharmaceuticals
RYTM
$7.95B
| $5.24M | ﹤0.01% |
113,915
-141,518
| -55% | -$4.46M |
|
3641
CALL
Box
BOX
$4.52B
| $5.23M | ﹤0.01% |
204,400
-179,700
| -47% | -$4.54M |
|
3642
PUT
Ares Capital
ARCC
$14.1B
| $5.23M | ﹤0.01% |
261,200
+30,000
| +13% | +$585K |
|
3643
PUT
Omega Healthcare
OHI
$14.1B
| $5.23M | ﹤0.01% |
170,500
-41,600
| -20% | -$1.33M |
|
3644
PUT
Alamos Gold
AGI
$14.2B
| $5.23M | ﹤0.01% |
387,900
+206,300
| +114% | +$2.7M |
|
|
IQIN
3645
DELISTED
NYLI 500 International ETF
IQIN
| $5.22M | ﹤0.01% |
159,144
+129,529
| +437% | +$4.03M |
|
3646
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.5B
| $5.22M | ﹤0.01% |
35,971
+24,417
| +211% | +$3.28M |
|
3647
Brunswick
BC
$5.36B
| $5.22M | ﹤0.01% |
53,902
-18,825
| -26% | -$1.5M |
|
3648
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $5.2M | ﹤0.01% |
39,500
-28,200
| -42% | -$3.25M |
|
3649
PUT
Expeditors International
EXPD
$24.2B
| $5.2M | ﹤0.01% |
40,900
+25,800
| +171% | +$3.04M |
|
3650
Aurinia Pharmaceuticals
AUPH
$2.03B
| $5.2M | ﹤0.01% |
578,665
-59,239
| -9% | -$488K |
|
Similar funds
Citadel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Citadel Advisors opened 1,585 new positions and closed 1,624 in Q4 2023.
- Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.